Table 3. Significantly altered pathways between PABS (n = 15) and ABS (n = 20).
Pathways | PABS vs. ABS | ||
p | Upregulated | Downregulated | |
Fatty acid biosynthesis | 1.72E-05 | Myristic acid Dodecanoic acid Palmitoleic acid Decanoic acid Stearic acid Oleic acid Palmitic acid |
|
Nitrogen metabolism | 0.000527 | Phenylalanine Tyrosine Tryptophan Aspartic acid Histidine |
|
Aminoacyl-tRNA biosynthesis | 0.001824 | Histidine Phenylalanine Aspartic acid Methionine Tryptophan Tyrosine |
|
Citrate cycle (TCA cycle) | 0.0049 | Pyruvic acid | Oxoglutaric acid Isocitric acid |
Alanine, aspartate, and glutamate metabolism | 0.008278 | Pyruvic acid | Aspartic acid Oxoglutaric acid |
Glyoxylate and dicarboxylate metabolism | 0.011203 | Pyruvic acid | Oxoglutaric acid Isocitric acid Oxalic acid |
Phenylalanine, tyrosine, and tryptophan biosynthesis | 0.011526 | Phenylalanine Tyrosine Tryptophan |
|
Linoleic acid metabolism | 0.028252 | Linoleic acid Bovinic acid |
|
Butanoate metabolism | 0.033159 | Pyruvic acid | Butyric acid Oxoglutaric acid |
Histidine metabolism | 0.04232 | Histidine Aspartic acid Oxoglutaric acid |
|
Phenylalanine metabolism | 0.04479 | Pyruvic acid | Phenylalanine Tyrosine |
Abbreviations: ABS, abstinence syndrome; PABS, post-abstinence syndrome; TCA, tricarboxylic acid.
p < 0.05 is significant.